Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q80YQ2

Entry ID Method Resolution Chain Position Source
6W1S EM 402 A R 1-1367 PDB
AF-Q80YQ2-F1 Predicted AlphaFoldDB

57 variants for Q80YQ2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3400416885 33 E>S No EVA
rs3400976742 37 L>I No EVA
rs3389103027 98 C>Y No EVA
rs51990989 105 D>A No EVA
rs3389067557 108 E>K No EVA
rs3389094199 112 T>R No EVA
rs3389102481 125 I>V No EVA
rs3389080473 130 D>V No EVA
rs3389102470 144 K>E No EVA
rs3389060612 162 A>T No EVA
rs3389094203 228 L>P No EVA
rs3389090158 229 P>A No EVA
rs3389093208 246 A>T No EVA
rs3389102472 248 L>M No EVA
rs3389080508 254 G>D No EVA
rs3389097684 259 D>V No EVA
rs3389060601 312 M>T No EVA
rs3389060673 328 Q>* No EVA
rs3389093026 353 V>A No EVA
rs3389090162 386 K>N No EVA
rs3389084793 396 M>L No EVA
rs3389037129 442 T>M No EVA
rs3389103040 512 T>M No EVA
rs3401080296 532 T>M No EVA
rs3389093050 572 V>L No EVA
rs3389067632 608 F>I No EVA
rs3389102455 649 A>V No EVA
rs3389093036 662 Q>K No EVA
rs3389097710 737 A>S No EVA
rs3400978924 810 V>A No EVA
rs3400632681 818 A>T No EVA
rs3389060695 875 E>* No EVA
rs3389084870 883 Y>H No EVA
rs3389094195 899 R>Q No EVA
rs3389067626 902 D>E No EVA
rs3389037191 918 H>R No EVA
rs3389097716 919 T>S No EVA
rs3389097680 933 Y>F No EVA
rs3389097651 953 P>H No EVA
rs3389084807 954 I>T No EVA
rs3389037110 1009 L>M No EVA
rs3389093101 1021 H>L No EVA
rs3389102503 1043 C>Y No EVA
rs3389037171 1046 D>Y No EVA
rs3389103018 1059 N>K No EVA
rs3389094239 1076 V>L No EVA
rs3389093073 1081 G>A No EVA
rs49883787 1083 S>C No EVA
rs248216484 1130 V>I No EVA
rs3389060643 1175 S>F No EVA
rs3389093348 1211 L>I No EVA
rs3389060677 1226 L>I No EVA
rs50396942 1242 E>Q No EVA
rs3389090187 1299 Y>* No EVA
rs3389067630 1307 G>D No EVA
rs3389097711 1353 A>V No EVA
rs47512542 1361 A>P No EVA

No associated diseases with Q80YQ2

No regional properties for Q80YQ2

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q80YQ2

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
core mediator complex A protein complex that interacts with the carboxy-terminal domain of the largest subunit of RNA polymerase II and plays an active role in transducing the signal from a transcription factor to the transcriptional machinery. The core mediator complex has a stimulatory effect on basal transcription, and contains most of the same subdomains as the larger form of mediator complex -- a head domain comprising proteins known in Saccharomyces as Srb2, -4, and -5, Med6, -8, and -11, and Rox3 proteins; a middle domain comprising Med1, -4, and -7, Nut1 and -2, Cse2, Rgr1, Soh1, and Srb7 proteins; and a tail consisting of Gal11p, Med2p, Pgd1p, and Sin4p -- but lacks the regulatory subcomplex comprising Ssn2, -3, and -8, and Srb8 proteins. Metazoan core mediator complexes have similar modular structures and include homologs of yeast Srb and Med proteins.
mediator complex A protein complex that interacts with the carboxy-terminal domain of the largest subunit of RNA polymerase II and plays an active role in transducing the signal from a transcription factor to the transcriptional machinery. The mediator complex is required for activation of transcription of most protein-coding genes, but can also act as a transcriptional corepressor. The Saccharomyces complex contains several identifiable subcomplexes: a head domain comprising Srb2, -4, and -5, Med6, -8, and -11, and Rox3 proteins; a middle domain comprising Med1, -4, and -7, Nut1 and -2, Cse2, Rgr1, Soh1, and Srb7 proteins; a tail consisting of Gal11p, Med2p, Pgd1p, and Sin4p; and a regulatory subcomplex comprising Ssn2, -3, and -8, and Srb8 proteins. Metazoan mediator complexes have similar modular structures and include homologs of yeast Srb and Med proteins.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
transcription regulator complex A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
ubiquitin ligase complex A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex.

1 GO annotations of molecular function

Name Definition
ubiquitin protein ligase activity Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues.

8 GO annotations of biological process

Name Definition
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
positive regulation of T cell extravasation Any process that activates or increases the frequency, rate or extent of T cell extravasation.
positive regulation of transcription elongation by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
positive regulation of transcription initiation by RNA polymerase II Any process that increases the rate, frequency or extent of a process involved in starting transcription from an RNA polymerase II promoter.
protein ubiquitination The process in which one or more ubiquitin groups are added to a protein.
regulation of DNA-templated transcription Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
RNA polymerase II preinitiation complex assembly The aggregation, arrangement and bonding together of proteins on an RNA polymerase II promoter DNA to form the transcriptional preinitiation complex (PIC), the formation of which is a prerequisite for transcription by RNA polymerase.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9W1X7 MED23 Mediator of RNA polymerase II transcription subunit 23 Drosophila melanogaster (Fruit fly) PR
Q9ULK4 MED23 Mediator of RNA polymerase II transcription subunit 23 Homo sapiens (Human) PR
Q5EB59 Med23 Mediator of RNA polymerase II transcription subunit 23 Rattus norvegicus (Rat) PR
Q10669 sur-2 Mediator of RNA polymerase II transcription subunit 23 Caenorhabditis elegans PR
10 20 30 40 50 60
METQLQSIFE EVVKTEIIEE AFPGMFMDTP EDEKTKLISC LAAFRQFWSG LSQESHEQCV
70 80 90 100 110 120
QWIVKFIHGQ HSPKRISFLY DCLAMAVETG LLPPRMVCES LINSDSLEWE RTQLWALTFK
130 140 150 160 170 180
LVRKIIGGVD YKGVRDLLKA ILEKILTIPN TVSSAVVQQL LAAREVIAYI LERNACLLPA
190 200 210 220 230 240
YFAVTEIRKL YPEGKLPHWL LGNLVSDFVD TFRPTARINS ICGRCSLLPV VNNSGAICNS
250 260 270 280 290 300
WKLDPATLRF PLKGLLPYDK DLFEPQTALL RYVLEQPYSR DMVCNMLGLN KQHKQRCPVL
310 320 330 340 350 360
EDQLVDLVVY AMERSETEEK FDDGGTSQLL WQHLSSQLIF FVLFQFASFP HMVLSLHQKL
370 380 390 400 410 420
AGRGLIKGRD HLMWVLLQFI SGSIQKNALA DFLPVMKLFD LLYPEKECIP VPDINKPQST
430 440 450 460 470 480
HAFAMTCIWI HLNRKAQNGD STLQIPIPHS LKLHHEFLQQ SLRNKSLQMN DYKIALLCNA
490 500 510 520 530 540
YSTNSECFTL PMGALVETIY GNGIMRVPLP GTSCLASASV TPLPMNLLDS LTVHAKMSLI
550 560 570 580 590 600
HSIATRVIKL AHTKSSVALA PALVETYSRL LVYMEIESLG IKGFISQLLP TVFKSHAWGI
610 620 630 640 650 660
LHTLLEMFSH RMHHIQPHYR VQLLSHLHTL AAVAQTNQNQ LHLCVESTAL RLITALGSSE
670 680 690 700 710 720
VQPQFTRFLN DPKTVLSAES EELNRALILT LARATHVTDF FTGSDSIQGT WCKDILQTIM
730 740 750 760 770 780
NFTPHNWASH TLSCFPAPLQ AFFKQNNVPQ ESRFNLKKNV EEEYRKWKSM TDENEIITQF
790 800 810 820 830 840
SVQGFPPLFL CLLWKMLLET DHISQIGYKV LERIGARALV AHVRTFADFL VYEFSTSAGG
850 860 870 880 890 900
QQLNKCIEIL NDMVWKYNIV TLDRLILCLA MRSHEGNEAQ VCYFIIQLLL LKPNDFRNRV
910 920 930 940 950 960
SDFVKENSPE HWLQSDWHTK HMSYHKKYPE KLYFEGLAEQ VDPPVPIQSP YLPIYFGNVC
970 980 990 1000 1010 1020
LRFLPVFDIV IHRFLELLPV SKSLETLLDH LGGLYKFHDR PVTYLYNTLH YYEMCLRNRD
1030 1040 1050 1060 1070 1080
HLKRKLVHAI IGSLKDNRPQ GWCLSDTYLK HAMNAREDNP WVPEDSYYCK LIGRLVDTMA
1090 1100 1110 1120 1130 1140
GKSPGPFPNC DWRFNEFPNP AAHALHVTCV ELMALAVPGK DVGNALLNVV LKSQPLVPRE
1150 1160 1170 1180 1190 1200
NITAWMNAIG LIITALPEPY WIVLHDRIVN VISSSSLTSE TEWVGYPFRL FDFTACHQSY
1210 1220 1230 1240 1250 1260
SEMSCSYTLA LAHAVWHHSS IGQLSLIPKF LTEALLPVVK TEFQLLYVYH LVGPFLQRFQ
1270 1280 1290 1300 1310 1320
QERTRCMIEI GVAFYDMLLN VDQCSTHLNY MDPICDFLYH MKYMFTGDSV KEQVEKIICN
1330 1340 1350 1360
LKPALKLRLR FITHISKMEP AVPPQALNSG SPAPQSNQVP ASLPVTQ